Status and phase
Conditions
Treatments
About
A randomized, controlled, double-masked, investigator-initiated trial to evaluate tear film quality and stability in subjects with dry eye disease using OC-01 (varenicline solution) nasal spray 0.03 mg as compared to vehicle control nasal spray.
Full description
A randomized, controlled, double-masked, investigator-initiated trial to evaluate tear film quality and stability in subjects with dry eye disease using OC-01 (varenicline solution) nasal spray 0.03 mg as compared to vehicle control nasal spray.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Subjects must:
Exclusion criteria
Subjects must not:
Primary purpose
Allocation
Interventional model
Masking
60 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Dee G Stephenson, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal